Aquestive Therapeutics, Inc.
AQST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001398733
In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Aquestive Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 46 | 46 | 0 |
| Shares | 16.6M | 15.9M | −746.0K (−4.5%) |
| Value | $10.7M | $18.6M | +$7.88M (+73.7%) |
New holders (6)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HighTower Advisors, LLC | 130,305 | $152.0K | 0.00% |
| Susquehanna International Group, LLP | 23,850 | $28.0K | 0.00% |
| Royal Bank of Canada | 20,087 | $23.0K | 0.00% |
| Gsa Capital Partners LLP | 13,704 | $16.0K | 0.00% |
| Bayesian Capital Management, LP | 10,235 | $12.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 499 | $1.00K | 0.00% |
Sold out (6)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| D. E. Shaw & Co., Inc. | 164,607 | $106.0K |
| Cowen and Company, LLC | 124,590 | $80.0K |
| Virtu Financial LLC | 106,408 | $68.0K |
| Engineers Gate Manager LP | 18,261 | $12.0K |
| Simplex Trading, LLC | 14,531 | $9.00K |
| BNP Paribas Arbitrage, SA | 1,136 | $727 |